ELT role responsible for strategy and commercial execution for Young's North America dealer business

ELT role focused on YI-wide business process improvement, EBITDA enhancement and M&A integrationKey accomplishments include:• Commercial diligence and overall integration lead for three acquisitions, with a combined annual revenue of >$70M• Built and managed team of engineers responsible for the identification and execution of EBITDA enhancing projects, resulting in >$1.5M in annual impact and >$5.5M pipeline• Stepped in to provide daily general management for a challenged segment of Young's business and drove a multi-month turnaround effort• Provided leadership and drove execution for Young's entrance into the medical nasal test swab market

ELT role responsible for Specialty segment of Young Innovations – initially three distinct business units and teams (Plak Smacker, Obtura Spartan, and Panoramic) with a combined annual revenue of >$35M and 90 total employees across three sites (CA, IL, IN).Marketed and sold a mix of self-manufactured, private label, and distributed general dental supplies,specialty supplies, and small and large equipment direct to general practitioners, specialists and government entities.Key accomplishments include:• Developed and executed multi-year strategy involving commercial and operational consolidation, outsourcing and exiting of non-core manufacturing, and investment in sales, marketing and distribution operations to build a combined scalable platform for growth• Commercial diligence and integration lead for six acquisitions, with a combined annual revenue of >$40M• Topgraded talent across the organization, primarily in sales and marketing• Implemented ROI-based marketing planning to improve EBITDA margins and reallocate marketingspend based on outcomes• Guided team through migration from different ERP/CRM systems to one common YI ERP/CRMplatform• Led project to launch new e-commerce website to improve customer experience and streamlineoperations• Launched new products across all business units to address portfolio gaps• Managed through a FDA warning letter and subsequent field actions• Drove revenue CAGR of 3% and EBITDA CAGR of 20%; exceeded EBITDA budget annually

Responsible for the organization's strategy, structure, and P&L.• Built and executed strategy to expand core blood bank portfolio and expand more broadly into the clinical laboratory• Grew team from seven to seventeen to drive new product development, add quality/regulatory competence, and increase commercial capacity• Directed turnaround of business's financial performance during tenure: - Increased revenue ~260%, changing CAGR from 0% to 17% - Increased gross profit ~225%, changing CAGR from -1% to 14% - Increased net income ~300%, changing CAGR from -27% to 22%

Responsible for developing annual marketing plans, assisting the R&D team in the development of new products, and managing Typenex's inside sales team

Responsible for managing Cardinal's self-manufactured fluid collection and disposal portfolio and developing a go-forward strategy and pipeline to address unmet clinical needs• Managed $80M suction canister portfolio • Renegotiated >$57M in existing contracted business at seven GPOs, leveraging a new pricing strategy that increased the profitability of the product portfolio and yielded new business opportunities in excess of $8M• Managed a Sr. Marketing Analyst with responsibility for $30M suction tubing, handles, and solidification portfolio• Led efforts to develop, market and launch an innovative operating room fluid collection and disposal system to address changing market needs; hired and managed three Marketing Managers to drive all launch efforts• Assisted with integration activities associated with acquisition of smoke evacuation company• Worked with R&D and manufacturing teams on product cost reduction initiatives

Responsible for product development and sustaining engineering efforts, primarily focused on Cardinal's self-manufactured pre-operative patient prep product portfolio• Developed and launched a new moisturizing healthcare personnel handwash• Re-designed and outsourced the manufacturing of a surgical prep razor, resulting in improved handle ergonomics and annual savings of $400K• Designed and managed the construction and validation of a new multimillion dollar plant to manufacture and package OTC drug solutions, resulting in annual savings of $850K and revenue growth of 20% due to improved formulations

Responsible for commissioning new evaporative process equipment and performing process evaluations and troubleshooting, primarily for customers in the pulp and paper industry